Kyma Medical Technologies has developed an innovative approach for remote monitoring of chronic heart failure (CHF) patients. Kyma’s miniature, non-invasive device utilizes novel body-penetrating microwave radar technology to monitor the optimal combination of CHF patient clinical parameters. The device is attached to the torso, thus requiring minimal patient intervention. Data are transferred wirelessly to a monitoring service provider, providing healthcare professionals with accurate and reliable information for timely clinical intervention. Kyma’s headquarters are in Kfar Saba, Israel, with a US office in Los Altos, CA.